# FebriDx® Method Comparison Study Protocol

> **NCT06746259** · — · COMPLETED · sponsor: **Lumos Diagnostics** · enrollment: 800 (actual)

## Conditions studied

- Acute Respiratory Infections (ARIs)

## Interventions

- **DIAGNOSTIC_TEST:** Rapid point of care test to detect host immune response in ARI

## Key facts

- **NCT ID:** NCT06746259
- **Lead sponsor:** Lumos Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-20
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-31
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06746259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06746259, "FebriDx® Method Comparison Study Protocol". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06746259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*